Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Jakubauskiene, L; Jakubauskas, M; Razanskiene, G; Leber, B; Weber, J; Rohrhofer, L; Ramasauskaite, D; Strupas, K; Stiegler, P; Schemmer, P.
Relaxin and Erythropoietin Significantly Reduce Uterine Tissue Damage during Experimental Ischemia-Reperfusion Injury.
INT J MOL SCI. 2022; 23(13): Doi: 10.3390/ijms23137120 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Stiegler Philipp
Co-Autor*innen der Med Uni Graz
Leber Bettina
Rohrhofer Lisa
Schemmer Peter
Weber Jennifer
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Successful uterus transplantation, a potential treatment method for women suffering from absolute uterine infertility, is negatively affected by ischemia-reperfusion injury (IRI). The aim of this study is to investigate the protective effect of relaxin (RLX) or/and erythropoietin (EPO) on experimental uterus IRI. Eighty rats, randomly assigned into eight groups (n = 10/group), were pretreated with either saline, 5 μg/kg human relaxin-2, 4000 IU/kg recombinant human erythropoietin or their combination. Ischemia was achieved by clamping the aorta and ovarian arteries for 60 min, following 120 min of reperfusion and tissue sampling. For sham animals, clamping was omitted during surgery. There were no differences in tissue histological score, malondialdehyde (MDA) and superoxide dismutase (SOD) levels, myeloperoxidase (MPO) and TUNEL-positive cell count between all sham-operated rats. Pretreatment with RLX preserved normal tissue morphology, reduced MDA levels, MPO and TUNEL-positive cell count, preserved SOD activity and upregulated NICD and HES1 gene expression when compared to the control group. Pretreatment with EPO reduced MDA levels. In conclusion, pretreatment with RLX, EPO or a combination of both EPO and RLX significantly alleviates uterine tissue damage caused by IRI.
Find related publications in this database (using NLM MeSH Indexing)
Animals - administration & dosage
Epoetin Alfa - administration & dosage
Erythropoietin - pharmacology, therapeutic use
Female - administration & dosage
Humans - administration & dosage
Rats - administration & dosage
Rats, Wistar - administration & dosage
Recombinant Proteins - pharmacology
Relaxin - pharmacology
Reperfusion Injury - metabolism
Superoxide Dismutase - metabolism
Uterus - metabolism

Find related publications in this database (Keywords)
transplantation
uterus
ischemia-reperfusion injury
relaxin
erythropoietin
© Med Uni Graz Impressum